Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction

• Status: Completed
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the dose limiting toxicity and the maximum tolerable dose of the radiochemotherapy with Docetaxel and Oxaliplatin in patients with adenocarcinoma of the gastric-oesophageal junction.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Johannes Gutenberg University Mainz
• Treatments: Docetaxel; Oxaliplatin

Criteria

Inclusion Criteria:

• adenocarcinoma of gastric-esophagal junction

• stage II to III

• unidimensional measurable disease

Exclusion Criteria:

• surgery of primary tumor

• metastasis

• prior chemo- or radiotherapy